Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 7/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | BAX | Q07812 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.46 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27597197 | 0.91 | LTA4H (0.55) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL28092325 | 0.89 | LTA4H (0.52) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL3841043 | 0.88 | LTA4H (0.50) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL3845620 | 0.88 | LTA4H (0.50) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL2883028 | 0.88 | LTA4H (0.50) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL20879853 | 0.87 | LTA4H (0.50) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL122719 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL22129853 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL3893562 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL435149 | 0.85 | LTA4H (0.92) | LTA4HTSHRNR1H2BAXMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114085300-B | Modified polybutadiene resin and preparation method and application thereof | 南亚新材料科技股份有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-114085300-A | Modified polybutadiene resin and preparation method and application thereof | 南亚新材料科技股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| WO-1994005618-A1 | PROCESS FOR THE PRODUCTION OF DIIODOKETONES | EASTMAN KODAK COMPANY (US) | 1994-03-17 | — | — | WO | claimed |
| US-4922010-A | Processes for preparing 2-substituted propionic acid and derivatives thereof | UBE INDUSTRIES, LTD. (JP) | 1990-05-01 | — | — | US | claimed |
| JP-62185047-A | — | — | None | — | — | JP | disclosed |
| JP-62161745-A | — | — | None | — | — | JP | disclosed |
| WO-2026086794-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2026-04-30 | — | — | WO | disclosed |
| US-20250304571-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2025-10-02 | — | — | US | disclosed |
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| US-20240425504-A1 | IMIDAZOPYRIDINONE COMPOUND | KISSEI PHARMACEUTICAL CO., LTD. (assignee) (JP) | 2024-12-26 | — | — | US | disclosed |
| EP-3808747-B1 | IMIDAZOPYRIDINONE COMPOUND | KISSEI PHARMACEUTICAL (JP) | 2024-12-18 | — | — | EP | disclosed |
| CN-118946340-A | Curable composition for dentistry having excellent color tone adaptability | 可乐丽则武齿科株式会社 | 2024-11-12 | — | — | CN | disclosed |
| EP-0488602-A1 | Aryl derivatives | ZENECA LIMITED (GB) | 1992-06-03 | — | — | EP | disclosed |
| EP-0415982-A1 | METHOD OF PREPARING AROMATIC ETHERS FROM IODOAROMATIC COMPOUNDS. | EASTMAN KODAK CO (US) | 1991-03-13 | — | — | EP | disclosed |
| US-4922010-A | Processes for preparing 2-substituted propionic acid and derivatives thereof | UBE INDUSTRIES, LTD. (JP) | 1990-05-01 | — | — | US | disclosed |
| WO-1989010912-A1 | METHOD OF PREPARING AROMATIC ETHERS FROM IODOAROMATIC COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1989-11-16 | — | — | WO | disclosed |
| WO-1989008630-A1 | METHOD FOR THE HALOGENATION OF AROMATIC COMPOUNDS | ZENOVA AB (SE) | 1989-09-21 | — | — | WO | disclosed |
| JP-S62185047-A | PRODUCTION OF DIPHENYL ETHER CARBOXYLIC ACID | ASAHI CHEM IND CO LTD | 1987-08-13 | — | — | JP | disclosed |
| JP-S62161745-A | PRODUCTION OF DIPHENYL ETHER CARBOXYLIC ACID ESTER | ASAHI CHEM IND CO LTD | 1987-07-17 | — | — | JP | disclosed |
| US-4567280-A | NITROGEN DIOXIDE; BY-PRODUCT INHIBITION | UBE INDUSTRIES, LTD. (JP) | 1986-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425504-A1 | IMIDAZOPYRIDINONE COMPOUND | EGLN3, DHPS, EGLN2 | LTA4H 323/4885TSHR 4705/4885NR1H2 943/4885 |
| US-20250304571-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | VHL, BRCA1, TERT | LTA4H 669/4885TSHR 4739/4885NR1H2 1044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.